Hepatic Toxicity After Selective Chemoembolization Is Associated With Decreased Survival Among Patients With Hepatocellular Carcinoma

Lokken R. Peter; Kerlan Robert K. Jr.; Chung Yu-Che; Chen Yi-Fan; Mehta Neil J.; Yao Francis Y.; Fidelman Nicholas

首页> 外文期刊>AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences >Hepatic Toxicity After Selective Chemoembolization Is Associated With Decreased Survival Among Patients With Hepatocellular Carcinoma

【24h】

Hepatic Toxicity After Selective Chemoembolization Is Associated With Decreased Survival Among Patients With Hepatocellular Carcinoma

机译：选择性化疗后的肝脏毒性与肝细胞癌患者的存活率下降有关

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

OBJECTIVE. The purpose of this study was to identify risk factors for and outcomes of hepatotoxicity after selective chemoembolization of hepatocellular carcinoma.

机译：None

著录项

来源
《AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences》 |2021年第5期|共8页
作者
Lokken R. Peter; Kerlan Robert K. Jr.; Chung Yu-Che; Chen Yi-Fan; Mehta Neil J.; Yao Francis Y.; Fidelman Nicholas;
展开▼
作者单位

Univ Calif San Francisco Dept Radiol &

Biomed Imaging Div Intervent Radiol 505 Parnassus Ave M;

Univ Calif San Francisco Dept Radiol &

Biomed Imaging Div Intervent Radiol 505 Parnassus Ave M;

Univ Illinois Sch Publ Hlth Div Epidemiol &

Biostat Chicago IL USA;

Univ Illinois Ctr Clin &

Translat Sci Chicago IL USA;

Univ Calif San Francisco Dept Med Div Gastroenterol San Francisco CA 94143 USA;

Univ Calif San Francisco Dept Med Div Gastroenterol San Francisco CA 94143 USA;

Univ Calif San Francisco Dept Radiol &

Biomed Imaging Div Intervent Radiol 505 Parnassus Ave M;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词
drug-eluting beads; hepatocellular carcinoma; hepatotoxicity; transcatheter arterial chemoembolization;

机译：药物洗脱珠子;肝细胞癌;肝毒性;经截面动脉化疗栓塞;

相似文献

外文文献
中文文献
专利

1. Transar terial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma:evaluation of tumor response, toxicity, and survival [J] . Timm D Kirchhoff, Tim F Greten, Stefan Kubicka, 国际肝胆胰疾病杂志（英文版） . 2007,第003期
2. Jinlong capsule decreases adverse reactions after transcatheter arterial chemoembolization (TACE) in patients with hepatocellular carcinoma [J] . Wukui Huang, Dengyao Liu, Lina You, 中德临床肿瘤学杂志（英文版） . 2015,第002期
3. Comparison of survival of patients with BCLC stage a hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: A propensity score-based analysis [J] . GuoZ., ZhongJ.-H., JiangJ.-H., Annals of surgical oncology . 2014,第9期

机译：肝切除或经动脉化学栓塞后BCLC分期的肝细胞癌患者生存期比较：基于倾向评分的分析
4. Comparison of survival of patients with BCLC stage a hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: A propensity score-based analysis [J] . GuoZ., ZhongJ.-H., JiangJ.-H., Annals of surgical oncology . 2014,第9期

机译：BCLC阶段患者存活的比较肝切除术后肝细胞癌肝癌栓塞术后：基于倾销的分数分析
5. Survival of infiltrative hepatocellular carcinoma patients with preserved hepatic function after treatment with transarterial chemoembolization [J] . JangE.S., YoonJ.-H., ChungJ.W., Journal of Cancer Research and Clinical Oncology . 2013,第4期

机译：经动脉化疗栓塞治疗的肝功能正常的浸润性肝细胞癌患者的生存
6. Hepatic Iron Accumulation and incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis C [C] . Namiki Izumi, Yasuhiro Asahina, Osamu Noguchi, Yamaguchi Symposium on Liver Disease . 2003

机译：慢性丙型肝炎患者肝脏铁累积和肝细胞癌发病率
7. Sesquiterpene drugs as potential treatment for hepatocellular carcinoma (HCC): Preclinical evaluation of parthenolide administered via transarterial chemoembolization in a rat HCC tumor model. [D] . Chen, Zheng. 2016

机译：倍半萜类药物可作为肝细胞癌（HCC）的潜在治疗方法：在大鼠HCC肿瘤模型中，通过经动脉化学栓塞术施用的小白菊内酯的临床前评估。
8. Increased Overall Survival and Decreased Cancer-Specific Mortality in Patients with Hepatocellular Carcinoma Treated by Transarterial Chemoembolization and Human Adenovirus Type-5 Combination Therapy: a Competing Risk Analysis [O] . Chaobin He, Yu Zhang, Xiaojun Lin -1

机译：经动脉化疗栓塞和人类5型腺病毒联合治疗治疗的肝细胞癌患者总体生存率增加和癌症特异性死亡率降低：竞争风险分析
9. Radiologic Response Combined with Dermatologic Toxicities is the Most Robust Predictor of Survival Benefits in Patients with Inoperable Hepatocellular Carcinoma After Transarterial Chemoembolization Plus Sorafenib Therapy [O] . Zhiqiu Ye, Zhizhen Deng, Suxiang Jiang, 2021

机译：与皮肤病有毒毒性的放射学反应是relarterial Chemoembolization Plus Sorafenib疗法患者患者患者中生存效果最强的预测因子
10. Defining Hepatocellular Carcinoma Subtypes and Treatment Responses in Patient-Derived Tumorgrafts. [R] . Yopp, A., Zhu, H., Singal, A., 2017

机译：定义肝细胞癌亚型和患者来源的肿瘤移植物的治疗反应。

Hepatic Toxicity After Selective Chemoembolization Is Associated With Decreased Survival Among Patients With Hepatocellular Carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅